Volume 71, Issue 2 pp. 169-178
Neurological Progress

High-frequency oscillations as a new biomarker in epilepsy

Maeike Zijlmans MD

Corresponding Author

Maeike Zijlmans MD

Department of Neurology and Neurosurgery, Rudolf Magnus Institute, University Medical Center Utrecht, the Netherlands

hp. G.03.228, Department of Neurology and neurosurgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The NetherlandsSearch for more papers by this author
Premysl Jiruska MD, PhD

Premysl Jiruska MD, PhD

Neuronal Networks Group, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom

Search for more papers by this author
Rina Zelmann MEng

Rina Zelmann MEng

Montreal Neurological Institute, McGill University, Montreal Québec, Canada

Search for more papers by this author
Frans S.S. Leijten MD, PhD

Frans S.S. Leijten MD, PhD

Department of Neurology and Neurosurgery, Rudolf Magnus Institute, University Medical Center Utrecht, the Netherlands

Search for more papers by this author
John G.R. Jefferys PhD

John G.R. Jefferys PhD

Neuronal Networks Group, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom

Search for more papers by this author
Jean Gotman PhD

Jean Gotman PhD

Montreal Neurological Institute, McGill University, Montreal Québec, Canada

Search for more papers by this author
First published: 02 August 2011
Citations: 397

Abstract

The discovery that electroencephalography (EEG) contains useful information at frequencies above the traditional 80Hz limit has had a profound impact on our understanding of brain function. In epilepsy, high-frequency oscillations (HFOs, >80Hz) have proven particularly important and useful. This literature review describes the morphology, clinical meaning, and pathophysiology of epileptic HFOs. To record HFOs, the intracranial EEG needs to be sampled at least at 2,000Hz. The oscillatory events can be visualized by applying a high-pass filter and increasing the time and amplitude scales, or EEG time-frequency maps can show the amount of high-frequency activity. HFOs appear excellent markers for the epileptogenic zone. In patients with focal epilepsy who can benefit from surgery, invasive EEG is often required to identify the epileptic cortex, but current information is sometimes inadequate. Removal of brain tissue generating HFOs has been related to better postsurgical outcome than removing the seizure onset zone, indicating that HFOs may mark cortex that needs to be removed to achieve seizure control. The pathophysiology of epileptic HFOs is challenging, probably involving populations of neurons firing asynchronously. They differ from physiological HFOs in not being paced by rhythmic inhibitory activity and in their possible origin from population spikes. Their link to the epileptogenic zone argues that their study will teach us much about the pathophysiology of epileptogenesis and ictogenesis. HFOs show promise for improving surgical outcome and accelerating intracranial EEG investigations. Their potential needs to be assessed by future research. Ann Neurol 2012;71:169–178

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me